Travis SPL - Search Results

1

Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti-TNF therapy in a tuberculosis endemic region.

Ye L, Chapman TP, Wen Z, Lin L, Qiu Y, Liu Z, Ran Z, Qian J, Wu K, Gao X, Hu P, Chen M, Travis SPL, Cao Q; Chinese IBD Elite Union. Ye L, et al. Among authors: travis spl. Aliment Pharmacol Ther. 2021 Feb;53(3):390-399. doi: 10.1111/apt.16130. Epub 2020 Dec 12. Aliment Pharmacol Ther. 2021. PMID: 33314259 Free PMC article.

2

The efficacy of methotrexate for maintaining remission in inflammatory bowel disease.

Fraser AG, Morton D, McGovern D, Travis S, Jewell DP. Fraser AG, et al. Aliment Pharmacol Ther. 2002 Apr;16(4):693-7. doi: 10.1046/j.1365-2036.2002.01227.x. Aliment Pharmacol Ther. 2002. PMID: 11929386 Free article.

3

How to manage the infectious risk under anti-TNF in inflammatory bowel disease.

Culver EL, Travis SP. Culver EL, et al. Curr Drug Targets. 2010 Feb;11(2):198-218. doi: 10.2174/138945010790310009. Curr Drug Targets. 2010. PMID: 20210768 Review.

4

Conventional medical management of inflammatory bowel disease.

Burger D, Travis S. Burger D, et al. Gastroenterology. 2011 May;140(6):1827-1837.e2. doi: 10.1053/j.gastro.2011.02.045. Gastroenterology. 2011. PMID: 21530749 Review.

5

What is the optimal treatment for anemia in inflammatory bowel disease?

Kent AJ, Blackwell VJ, Travis SP. Kent AJ, et al. Curr Drug Deliv. 2012 Jul;9(4):356-66. doi: 10.2174/156720112801323026. Curr Drug Deliv. 2012. PMID: 22023204 Review.

6

The future of inflammatory bowel disease management: combining progress in trial design with advances in targeted therapy.

Travis S, Feagan BG, Rutgeerts P, van Deventer S. Travis S, et al. J Crohns Colitis. 2012 Feb;6 Suppl 2:S250-9. doi: 10.1016/S1873-9946(12)60505-4. J Crohns Colitis. 2012. PMID: 22463932 Review.

7

Letter: inflammatory bowel disease guidelines and conflicts of interest.

Eliakim R, Dignass A, Travis S. Eliakim R, et al. Aliment Pharmacol Ther. 2013 Aug;38(4):445. doi: 10.1111/apt.12395. Aliment Pharmacol Ther. 2013. PMID: 23855401 Free article. No abstract available.

8

Conventional drug therapy for inflammatory bowel disease.

Bryant RV, Brain O, Travis SP. Bryant RV, et al. Scand J Gastroenterol. 2015 Jan;50(1):90-112. doi: 10.3109/00365521.2014.968864. Scand J Gastroenterol. 2015. PMID: 25523560 Review.

9

Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease.

Wu KC, Ran ZH, Gao X, Chen M, Zhong J, Sheng JQ, Kamm MA, Travis S, Wallace K, Mostafa NM, Shapiro M, Li Y, Thakkar RB, Robinson AM. Wu KC, et al. Intest Res. 2016 Apr;14(2):152-63. doi: 10.5217/ir.2016.14.2.152. Epub 2016 Apr 27. Intest Res. 2016. PMID: 27175116 Free PMC article.

10

Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease-an International, Cross-disciplinary Consensus.

Kim AH, Roberts C, Feagan BG, Banerjee R, Bemelman W, Bodger K, Derieppe M, Dignass A, Driscoll R, Fitzpatrick R, Gaarentstroom-Lunt J, Higgins PD, Kotze PG, Meissner J, O'Connor M, Ran ZH, Siegel CA, Terry H, van Deen WK, van der Woude CJ, Weaver A, Yang SK, Sands BE, Vermeire S, Travis SP. Kim AH, et al. J Crohns Colitis. 2018 Mar 28;12(4):408-418. doi: 10.1093/ecco-jcc/jjx161. J Crohns Colitis. 2018. PMID: 29216349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

333 results

Search Page

Filters